Showing results (11-20 of 92) with videos related to
Sort By:
Pageof 10
Kidney & Blood Pressure Research|May 29, 2003
Cytokine removal in septic patients with continuous venovenous hemofiltrationP Heering, B Grabensee, M BrauseLeukemia|April 1, 1997
Prophylactic strategies to meet infectious complications in fludarabine-treated CLLT Südhoff, M Arning, W SchneiderMedizinische Klinik (Munich, Germany : 1983)|November 11, 1999
[Systemic Al-amyloidosis. Clinical course and limits of melphalan therapy]G R Hetzel, P Heering, B GrabenseeInternational Urology and Nephrology|April 9, 1999
Cardiovascular risk factors and diseases after renal transplantationS Aker, K Ivens, B Grabensee, et al.European Journal of Clinical Investigation|November 26, 2003
COX-2 inhibition and prostaglandin receptors in experimental nephritisC Waldner, G Heise, K Schrör, et al.The Clinical Investigator|December 1, 1993
Nephrotoxicity of cyclosporine in humans: effect of cyclosporine on glomerular filtration and proximal tubular reabsorptionP Heering, P Schadewaldt, D Bach, et al.Medizinische Klinik (Munich, Germany : 1983)|November 2, 1999
[Incidence of cardiovascular risk factors and complications after kidney transplantation]K Ivens, S Aker, B Grabensee, et al.Deutsche Medizinische Wochenschrift (1946)|November 1, 2001
[Glomerulonephritis secondary to chronic infection of a ventriculoatrial shunt]F Ozcan, M Sabel, P Heering, et al.Klinische Wochenschrift|May 4, 1990
[Effect of a beta 1-receptor blocker on the plasma level of atrial natriuretic peptide in patients with essential hypertension in the exercise test]J Plum, M Hollenbeck, P Heering, et al.Nephron|January 1, 1992
The role of thromboxane and prostacyclin in ciclosporin-induced nephrotoxicityP Heering, H Strobach, K Schrör, et al.Pageof 10